Canada Life’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-193
| Closed | -$12K | – | 2176 |
|
|
2023
Q3 | $12K | Hold |
193
| – | – | ﹤0.01% | 2195 |
|
|
2023
Q2 | $13K | Hold |
193
| – | – | ﹤0.01% | 2221 |
|
|
2023
Q1 | $12K | Hold |
193
| – | – | ﹤0.01% | 2285 |
|
|
2022
Q4 | $27K | Buy |
+193
| New | +$27.2K | ﹤0.01% | 2199 |
|
|
2022
Q2 | – | Sell |
-204
| Closed | -$20K | – | 2434 |
|
|
2022
Q1 | $20K | Buy |
204
+13
| +7% | +$1.72K | ﹤0.01% | 2347 |
|
|
2021
Q4 | $38K | Sell |
191
-86
| -31% | -$20.3K | ﹤0.01% | 2244 |
|
|
2021
Q3 | $69K | Hold |
277
| – | – | ﹤0.01% | 2146 |
|
|
2021
Q2 | $115K | Sell |
277
-64
| -19% | -$25.4K | ﹤0.01% | 2048 |
|
|
2021
Q1 | $132K | Hold |
341
| – | – | ﹤0.01% | 2038 |
|
|
2020
Q4 | $191K | Hold |
341
| – | – | ﹤0.01% | 1974 |
|
|
2020
Q3 | $238K | Hold |
341
| – | – | ﹤0.01% | 1854 |
|
|
2020
Q2 | $268K | Buy |
341
+41
| +14% | +$30.9K | ﹤0.01% | 1831 |
|
|
2020
Q1 | $180K | Hold |
300
| – | – | ﹤0.01% | 1842 |
|
|
2019
Q4 | $338K | Buy |
300
+22
| +8% | +$23.9K | ﹤0.01% | 1810 |
|
|
2019
Q3 | $331K | Sell |
278
-250
| -47% | -$382K | ﹤0.01% | 956 |
|
|
2019
Q2 | $869K | Sell |
528
-57
| -10% | -$98.6K | ﹤0.01% | 1604 |
|
|
2019
Q1 | $1.19M | Buy |
585
+80
| +16% | +$141K | ﹤0.01% | 1327 |
|
|
2018
Q4 | $627K | Buy |
505
+78
| +18% | +$120K | ﹤0.01% | 1591 |
|
|
2018
Q3 | $808K | Hold |
427
| – | – | ﹤0.01% | 1608 |
|
|
2018
Q2 | $868K | Hold |
427
| – | – | ﹤0.01% | 1580 |
|
|
2018
Q1 | $946K | Hold |
427
| – | – | ﹤0.01% | 1533 |
|
|
2017
Q4 | $983K | Hold |
427
| – | – | ﹤0.01% | 1534 |
|
|
2017
Q3 | $778K | Buy |
427
+79
| +23% | +$110K | ﹤0.01% | 1600 |
|
|
2017
Q2 | $473K | Hold |
348
| – | – | ﹤0.01% | 1725 |
|
|
2017
Q1 | $409K | Buy |
348
+77
| +28% | +$78.5K | ﹤0.01% | 1756 |
|
|
2016
Q4 | $218K | Sell |
271
-100
| -27% | -$79.4K | ﹤0.01% | 1892 |
|
|
2016
Q3 | $325K | Buy |
371
+117
| +46% | +$84.7K | ﹤0.01% | 1779 |
|
|
2016
Q2 | $142K | Hold |
254
| – | – | ﹤0.01% | 1977 |
|
|
2016
Q1 | $139K | Hold |
254
| – | – | ﹤0.01% | 1552 |
|
|
2015
Q4 | $211K | Hold |
254
| – | – | ﹤0.01% | 1256 |
|
|
2015
Q3 | $282K | Buy |
254
+53
| +26% | +$96.6K | ﹤0.01% | 1065 |
|
|
2015
Q2 | $437K | Hold |
201
| – | – | ﹤0.01% | 1044 |
|
|
2015
Q1 | $313K | Hold |
201
| – | – | ﹤0.01% | 1116 |
|
|
2014
Q4 | $238K | Hold |
201
| – | – | ﹤0.01% | 1220 |
|
|
2014
Q3 | $94K | Buy |
+201
| New | +$92.7K | ﹤0.01% | 1740 |
|
Other funds holding BLUE
GIM
PAI
GCM
Canada Life's BLUE Position: Q4 2023 in Review
Canada Life sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 193 shares — an estimated $12K sold.
Canada Life first reported a position in BLUE in Q3 2014 and held it in 35 quarters. The position peaked at $1.19M in Q1 2019. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.
- Canada Life reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
- Canada Life sold 193 bluebird bio shares in Q4 2023, an estimated $12K.
- Canada Life first reported a position in bluebird bio in Q3 2014 and held it in 35 quarters.
- Canada Life's bluebird bio position peaked at $1.19M in Q1 2019.
- 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.
Based on Canada Life's 13F filing for Q4 2023, filed 13 Feb 2024.